Pharmaceutical drugs supplied by: Rigel Pharmaceuticals, Inc.
✉ Email this page to a colleague
Rigel Pharmaceuticals, Inc.
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Rigel Pharms | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299 | NDA | Rigel Pharmaceuticals, Inc. | 71332-001-01 | 60 TABLET in 1 BOTTLE (71332-001-01) | 2018-05-09 |
| Rigel Pharms | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299 | NDA | Rigel Pharmaceuticals, Inc. | 71332-002-01 | 60 TABLET in 1 BOTTLE (71332-002-01) | 2018-05-09 |
| Rigel Pharms | REZLIDHIA | olutasidenib | CAPSULE;ORAL | 215814 | NDA | Rigel Pharmaceuticals, Inc. | 71332-005-01 | 30 CAPSULE in 1 BOTTLE (71332-005-01) | 2022-12-01 |
| Rigel Pharms | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721 | NDA | Rigel Pharmaceuticals, Inc. | 71332-006-12 | 120 CAPSULE in 1 BOTTLE (71332-006-12) | 2024-06-24 |
| Rigel Pharms | GAVRETO | pralsetinib | CAPSULE;ORAL | 213721 | NDA | Rigel Pharmaceuticals, Inc. | 71332-006-60 | 60 CAPSULE in 1 BOTTLE (71332-006-60) | 2024-06-24 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
